Position in UTHR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$15,621,500
-$189,718 QoQ
Shares Held
28,831
+8.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#141
of 874 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $19,400,632 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (80.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
28,831 | $15,621,500 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
19,700 | $3,320,238 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
40,000 | $400,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,674 | $58,894 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
0 | $0 | |
| 6 | ZTS |
Zoetis Inc.
|
0 | $0 |
All Filings in UTHR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,621,500 | 28,831 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $15,811,218 | 26,664 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $20,957,109 | 43,011 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $15,841,107 | 37,788 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,345,130 | 42,962 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,113,469 | 39,295 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,631,466 | 47,136 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16,221,071 | 45,266 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,987,777 | 47,050 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $10,671,183 | 46,453 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $9,408,872 | 42,789 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $8,798,539 | 38,954 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $8,341,701 | 37,788 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $8,000,075 | 35,721 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $8,187,247 | 29,441 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $3,093,589 | 14,775 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $3,422,199 | 14,523 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $2,504,563 | 13,960 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $2,660,160 | 12,311 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $1,938,090 | 10,500 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $1,883,805 | 10,500 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $0 | 0 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $0 | 0 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $0 | 0 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||